Lista de obras -

A lymphocyte-mediated cause of secondary PAP.

artículo científico publicado en 2015

A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry

artículo científico publicado en 2014

Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

artículo científico publicado en 2002

Assessment and management of pulmonary alveolar proteinosis in a reference center

artículo científico publicado en 2013

Cell Therapy for Lung Diseases. Report from an NIH–NHLBI Workshop, November 13–14, 2012 ⬇️

artículo científico publicado el 1 de agosto de 2013

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan

artículo científico publicado en 2008

Complete Tracheal Ring Deformity. A Translational Genomics Approach to Pathogenesis

scientific article published on 01 November 2019

Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme

artículo científico publicado en 2015

Diffuse lung disease in young children: application of a novel classification scheme

artículo científico publicado en 2007

Does Granulocyte-Macrophage Colony-Stimulating Factor Coordinate a Hepatopulmonary Axis of Lipid Metabolism?

artículo científico publicado en 2017

Early changes in clinical, functional, and laboratory biomarkers in workers at risk of indium lung disease

artículo científico publicado en 2014

Efficacy and safety of sirolimus in lymphangioleiomyomatosis

artículo científico publicado en 2011

Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

artículo científico publicado en 2008

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection ⬇️

artículo científico publicado el 17 de noviembre de 2011

Genetic disorders influencing lung formation and function at birth

artículo científico publicado en 2004

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

artículo científico publicado en 2002

Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice

artículo científico publicado en 2011

Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease

artículo científico publicado en 2013

Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice.

scientific article published on October 2008

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects

artículo científico publicado en 2009

Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy

artículo científico publicado en 2010

High avidity cytokine autoantibodies in health and disease: pathogenesis and mechanisms

artículo científico publicado en 2010

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis

artículo científico publicado en 2009

Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression

artículo científico publicado en 2013

Increased Prevalence of Luminal Narrowing and Stricturing Identified by Enterography in Pediatric Crohn’s Disease Patients With Elevated Granulocyte–Macrophage Colony Stimulating Factor Autoantibodies ⬇️

artículo científico publicado el 1 de septiembre de 2013

Indium Lung Disease ⬇️

artículo científico publicado el 29 de diciembre de 2011

Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis

artículo científico publicado en 2010

Innate Dysfunction Promotes Linear Growth Failure in Pediatric Crohnʼs Disease and Growth Hormone Resistance in Murine Ileitis§ ⬇️

artículo científico publicado el 18 de febrero de 2011

Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages

artículo científico publicado en 2011

Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury

artículo científico publicado en 2010

Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review

artículo científico publicado en 2007

Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates

artículo científico publicado en 2010

Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe

artículo científico publicado en 2012

Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results

artículo científico publicado en 2011

Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer.

artículo científico publicado en 2010

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

artículo científico publicado en 2017

Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages

artículo científico publicado en 2009

Pulmonary macrophage transplantation therapy

artículo científico publicado en 2014

Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle

artículo científico publicado en 2015

Respirable indium exposures, plasma indium, and respiratory health among indium-tin oxide (ITO) workers

artículo científico publicado en 2016

Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial

artículo científico publicado en 2013

Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases

artículo científico publicado en 2010

Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.

artículo científico publicado en 2013

The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development?

artículo científico publicado en 2019

The molecular basis of pulmonary alveolar proteinosis

artículo científico publicado en 2010

The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis

artículo científico publicado en 2013

Therapy options in pulmonary alveolar proteinosis.

scientific article published on 20 July 2010

Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis

artículo científico publicado en 2014

Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures.

artículo científico publicado en 2016

alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.

artículo científico publicado en 2008

Lista de obras de

A lymphocyte-mediated cause of secondary PAP.

A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry

Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Assessment and management of pulmonary alveolar proteinosis in a reference center

Cell Therapy for Lung Diseases. Report from an NIH–NHLBI Workshop, November 13–14, 2012 ⬇️

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan

Complete Tracheal Ring Deformity. A Translational Genomics Approach to Pathogenesis

Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme

Diffuse lung disease in young children: application of a novel classification scheme

Does Granulocyte-Macrophage Colony-Stimulating Factor Coordinate a Hepatopulmonary Axis of Lipid Metabolism?

Early changes in clinical, functional, and laboratory biomarkers in workers at risk of indium lung disease

Efficacy and safety of sirolimus in lymphangioleiomyomatosis

Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection ⬇️

Genetic disorders influencing lung formation and function at birth

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice

Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease

Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice.

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects

Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy

High avidity cytokine autoantibodies in health and disease: pathogenesis and mechanisms

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis

Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression

Increased Prevalence of Luminal Narrowing and Stricturing Identified by Enterography in Pediatric Crohn’s Disease Patients With Elevated Granulocyte–Macrophage Colony Stimulating Factor Autoantibodies ⬇️

Indium Lung Disease ⬇️

Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis

Innate Dysfunction Promotes Linear Growth Failure in Pediatric Crohnʼs Disease and Growth Hormone Resistance in Murine Ileitis§ ⬇️

Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages

Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury

Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review

Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates

Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe

Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results

Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer.

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages

Pulmonary macrophage transplantation therapy

Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle

Respirable indium exposures, plasma indium, and respiratory health among indium-tin oxide (ITO) workers

Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial

Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases

Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.

The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development?

The molecular basis of pulmonary alveolar proteinosis

The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis

Therapy options in pulmonary alveolar proteinosis.

Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis

Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures.

alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.